Wall Street analysts are broadly positive on pipeline operator Kinder Morgan, but investors should be cautious about leaning on those endorsements alone, according to a fresh snapshot of sell‑side recommendations. The company’s average brokerage recommendation (ABR) sits at 2.00 on a 1–5 scale — a “Buy” — based on ratings from 23 brokerage firms, a new aggregation shows.
The makeup of that consensus is heavily tilted toward the top end: 11 of the 23 firms have issued “Strong Buy” ratings and one has issued a “Buy,” meaning roughly 52% of the panel recommends purchasing the stock (47.8% Strong Buy; 4.4% Buy). The ABR figure is reported to two decimal places in some services but here is presented as the round 2.00 Buy level that investors commonly see when scanning analyst pages.
Analyst recommendations move headlines and can influence short‑term price action, but academic and industry research has repeatedly questioned their long‑term predictive power. The new report highlights that brokerage houses tend toward optimism — assigning roughly five “Strong Buy” recommendations for every “Strong Sell” — and warns that this structural bias reflects potential conflicts between brokerages’ business interests and the interests of retail investors.
Because of that asymmetry, the aggregation’s authors advise using the ABR as one input rather than a sole decision driver. In practice, the brokerage consensus can serve as a sanity check for investor research: if the analyst crowd’s view aligns with independent quantitative or fundamental work, it can increase confidence; if it diverges markedly, that may signal a need for deeper scrutiny.
One alternative measure presented alongside brokerage sentiment is the Zacks Rank, a proprietary, number‑based model built on earnings estimate revisions. Unlike the ABR — which is a compilation of human analysts’ Buy/Hold/Sell judgments and often shown with decimals — the Zacks Rank categorizes securities from 1 (Strong Buy) to 5 (Strong Sell) and is driven by changes in analysts’ earnings forecasts. The current coverage recommends treating the ABR and Zacks Rank as complementary: use the brokerage tally to validate, but rely on systematic tools like Zacks for a different lens on near‑term price momentum.
Investors considering Kinder Morgan should therefore weigh the bullish broker consensus against independent evaluation of the company’s fundamentals and any quantitative signal they trust. The new ABR data confirms Wall Street’s present tilt toward KMI, but the report underscores that the endorsement is not an unequivocal prediction of future outperformance.